Pulse Biosciences

NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. We believe that NPES can induce a variety of cellular responses including secretion, apoptosis and necrosis by modulating the NPES pulses, making it applicable to a wide variety of cell types and therapeutic applications. One of the more promising applications of NPES is the treatment of solid tumors, where pre-clinical data have shown that NPES provides effective local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. We believe we will establish NPES as a new treatment modality across a variety of applications, including oncology, dermatology, and other minimally invasive applications where current ablation modalities do not provide the benefits of NPES.
Type
Public
HQ
Burlingame, US
Pulse Biosciences is headquartered in Burlingame, US

Pulse Biosciences Office Locations

Pulse Biosciences has office in Burlingame
Burlingame, US

Pulse Biosciences Metrics

Pulse Biosciences Summary

Market capitalization

$194 M

Closing share price

$15.1
Pulse Biosciences's current market capitalization is $194 M.

Pulse Biosciences Market Value History

Pulse Biosciences Company Life

You may also be interested in